stockrow
Saturday 14 November 2026
Export BRSHF’s income statement to Excel — free account
Bruush Oral Care Inc.
BRSHFConsumer Defensive Household & Personal Products
0.00
0.00
NaN
Follow BRSHF
Alert me
| Oct '20 | Oct '21 | Oct '22 | Dec '22 | |
|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | — |
P/S ratio |
0.00 | 0.00 | 5.24 | — |
P/FCF ratio |
68.96 | 68.96 | 1.32 | — |
Altman Z″-Score (non-manufacturers) |
(62.63) | (72.21) | — | — |
P/Operating CF |
20,963.70 | 20,963.70 | 2.64 | — |
P/B ratio |
0.00 | 0.00 | 0.00 | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | — |
EV/Sales |
0.00 | 0.00 | 7.83 | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
102.24 | 102.24 | 1.97 | — |
EV/FCF |
105.60 | 105.60 | 1.97 | — |
Quick Ratio |
0.27 | 0.41 | 0.10 | 0.10 |
Current Ratio |
1.12 | 1.08 | 0.46 | 0.46 |
Net Debt/EBITDA |
(0.21) | 0.08 | 0.00 | 0.00 |
Debt/Assets |
87.89% | 0.85% | 0.00% | 0.00% |
Debt/Equity |
(2.00) | 0.11 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.70 | 0.00 | 0.00 |
Operating CF/Net income |
1.06 | 0.46 | 0.00 | 0.00 |
Capex/Depreciation |
— | — | 0.00 | 0.00 |
Interest Coverage |
(160.32) | (880.61) | — | — |
| 0.00% | 33,049.81% | 0.00% | 0.00% | |
| 0.00% | (693.10%) | 0.00% | 0.00% | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(1,622.24%) | (5,450.89%) | 0.00% | 0.00% |
Average Days of Receivables |
22.88 | 32.89 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
637.85% | 392.43% | 355.13% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | — |
Graham Net Nets |
0.06 | 0.06 | (0.16) | — |
Graham Number |
0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(485.55%) | (485.55%) | (485.60%) | — |
Free Cash Flow Yield |
1.45% | 1.45% | 75.70% | — |
Revenue per Share |
0.71 | 3.07 | 13.71 | — |
Operating CF per Share |
(4.97) | (13.80) | 0.00 | 0.00 |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(4.97) | (13.80) | 0.00 | 0.00 |
Cash per Share |
0.62 | 2.36 | 0.00 | 0.00 |
Shareholders Equity per Share |
(0.74) | 0.56 | 0.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | — |
Book value per Share |
(0.74) | 0.56 | 0.00 | 0.00 |
Free Cash Flow |
(1.46) | (4.05) | 0.00 | 0.00 |
Working Capital |
0.09 | 0.16 | (1.41) | (1.41) |
Capital Expenditures |
— | 0.00 | 0.00 | 0.00 |
Net Current Asset Value |
0.09 | 0.16 | (1.41) | (1.41) |
EV/EBIT |
0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | — |
| Other line items | ||||
Depreciation/Fixed assets |
— | 0.00 | 0.00 | 0.00 |
Cash ROIC |
(366.92%) | (464.03%) | 0.00% | 0.00% |
Accounts Receivable Turnover |
0.00 | 19.13 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 21.57 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 6.01 | 0.00 | 0.00 |
Average Days of Payables |
791.04 | 16.20 | 0.00 | 0.00 |
Days of Inventory on Hand |
1,836.04 | 80.48 | 0.00 | 0.00 |
Average Receivables |
— | 0.05 | 0.13 | 0.18 |
Average Payables |
— | 0.25 | 0.79 | 1.35 |
Average Inventory |
— | 0.89 | 0.71 | 0.24 |
Average Assets |
— | 1.28 | 1.63 | 1.19 |
Average Common Equity |
— | (0.03) | (0.62) | (1.40) |
Columns are period end dates · fundamentals updated 26 Oct 2026